Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 13, 2024

Total Value: $261M (100.0% shares, 0.0% debt)

Holdings (16)

BBIO BridgeBio Pharma Inc. (BBIO) 59.2%

Value $154M Shares 6,068,125 Est. Cost $40.43 Unrealized -35.1%

— Verona Pharma plc (VRNA) 12.3%

Value $32.09M Shares 1,115,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 7.6%

Value $19.73M Shares 1,025,000 Est. Cost $10.24 Unrealized +101.8%

BCAX Bicara Therapeutics Inc. (BCAX) 5.6%

Value $14.49M Shares 568,919 Est. Cost $25.50 Unrealized 0.0%

BMEA Biomea Fusion Inc (BMEA) 3.1%

Value $8.067M Shares 798,757 Est. Cost $17.65 Unrealized -63.2%

GLUE Monte Rosa Therapeutics Inc (GLUE) 3.0%

Value $7.803M Shares 1,472,331 Est. Cost $20.37 Unrealized -75.2%

CMPS Compass Pathways Plc (CMPS) 2.3%

Value $6.076M Shares 964,500 Est. Cost $7.40 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 2.2%

Value $5.819M Shares 2,541,009 Est. Cost $11.18 Unrealized -72.7%

— Poseida Therapeutics Inc. (PSTX) 1.1%

Value $2.984M Shares 1,043,267 Est. Cost $8.87 Unrealized —

TECX Tectonic Therapeutic Inc (TECX) 1.0%

Value $2.55M Shares 84,148 Est. Cost $15.77 Unrealized +15.9%

CALC CalciMedica, Inc. (CALC) 0.9%

Value $2.309M Shares 521,114 Est. Cost $4.55 Unrealized -3.4%

— Elevation Oncology Inc (ELEV) 0.7%

Value $1.701M Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Reneo Pharmaceuticals Inc (RPHM) 0.6%

Value $1.506M Shares 886,075 Est. Cost $9.33 Unrealized —

MRKR Marker Therapeutics, Inc. (MRKR) 0.3%

Value $886K Shares 314,286 Est. Cost $1.74 Unrealized +127.6%

ACRS Aclaris Therapeutics Inc (ACRS) 0.2%

Value $500K Shares 434,455 Est. Cost $10.31 Unrealized -88.1%

— Viracta Therapeutics Inc (VIRX) 0.0%

Value $66,371 Shares 288,571 Est. Cost $11.34 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$154M	59.2%	$40.43	-35.1%	COM	10806X102
—	Verona Pharma plc (VRNA)	1,115,352	$32.09M	12.3%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$19.73M	7.6%	$10.24	+101.8%	COM	87164F105
BCAX	Bicara Therapeutics Inc. (BCAX)	568,919	$14.49M	5.6%	$25.50	0.0%	COM	055477103
BMEA	Biomea Fusion Inc (BMEA)	798,757	$8.067M	3.1%	$17.65	-63.2%	COM	09077A106
GLUE	Monte Rosa Therapeutics Inc (GLUE)	1,472,331	$7.803M	3.0%	$20.37	-75.2%	COM	61225M102
CMPS	Compass Pathways Plc (CMPS)	964,500	$6.076M	2.3%	$7.40	—	SPONSORED ADS	20451W101
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$5.819M	2.2%	$11.18	-72.7%	COM CL A	67080N101
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$2.984M	1.1%	$8.87	—	COM	73730P108
TECX	Tectonic Therapeutic Inc (TECX)	84,148	$2.55M	1.0%	$15.77	+15.9%	COM	878972108
CALC	CalciMedica, Inc. (CALC)	521,114	$2.309M	0.9%	$4.55	-3.4%	COM NEW	38942Q202
—	Elevation Oncology Inc (ELEV)	2,834,910	$1.701M	0.7%	$13.57	—	COM	28623U101
—	Reneo Pharmaceuticals Inc (RPHM)	886,075	$1.506M	0.6%	$9.33	—	COM	75974E103
MRKR	Marker Therapeutics, Inc. (MRKR)	314,286	$886K	0.3%	$1.74	+127.6%	COM NEW	57055L206
ACRS	Aclaris Therapeutics Inc (ACRS)	434,455	$500K	0.2%	$10.31	-88.1%	COM	00461U105
—	Viracta Therapeutics Inc (VIRX)	288,571	$66,371	0.0%	$11.34	—	COM	92765F108